Drug Discovery & Development

Ymmunobio get ownership rights to NPTXR antibodies. Read more here:

https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-to-nptxr-antibodies/

Fierce Biotech: Appointment of Michel Janicot

Michel Janicot will serve in the newly created position of chief development officer.

https://www.fiercebiotech.com/biotech/chutes-ladders-novavax-ceo-erck-bids-adieu-after-12-years-overseeing-covid-vax-development

Ymmunobio Appoints Dr. Michel Janicot as Chief Development Officer

Ymmunobio adds to executive team.

Read more here: https://www.biopharmadive.com/press-release/20230109-ymmunobio-appoints-dr-michel-janicot-as-chief-development-officer/